Use of modified oligobeta-(1,3)-glucanes for treating diseases of the immune system, oligobeta- (1,3v-glucane-(1,3)- mannose, oligo-beta-(1,3)-glucane-(1,3)- mannitol and derivatives thereof, methods for preparing the same and drugs containing them
Details for Australian Patent Application No. 2007344284 (hide)
International Classifications
Event Publications
30 July 2009 PCT application entered the National Phase
PCT publication WO2008/087340 Priority application(s): WO2008/087340
24 September 2009 Assignment before Grant
LABORATOIRE DE LA MER The application has been assigned to Laboratoires Goemar 2008
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007344292-Emulsion comprising at least one retinoid and benzoyl peroxide
2007344279-Method for preparing polyamide powder by anionic polymerisation
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser